Depression. Depressive episode
Conditions
Interventions
Intervention 1: 500 mg powder of Fluoxetine ( Exir ) capsules twice in day for 6 weeks. Intervention 2: 500mg Cuscuta capsule twice in day for 6 weeks.
Treatment - Drugs
500 mg powder of Fluoxetine ( Exir ) capsules twice in day for 6 weeks
500mg Cuscuta capsule twice in day for 6 weeks
Sponsors
Shiraz university of medical science
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Inclusion: patients over 18 with the diagnosis of depression based on DSM5 and Beck criteria, patients with written informed consent. Exclusion: Other underlying psychological disorder like Schizophrenia, schizoaffective, bipolar disorder, psychotic disorder, organic disorder make depression directly like hypothyroidism, pregnancy lactation, addiction, patients with suicidal thought and the patients. Who may need electronic convulsive therapy (ECT), being under the treatment of antidepressant on 1 month ago, chronic respiratory disease and past history of drug reaction to Cuscuta.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Depression. Timepoint: baseline , after intervention on second,4th and 6th week. Method of measurement: Beck depression inventory. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effect like unusual drug reaction, GI discomfort. Timepoint: During the clinical trial specially on second,4th and 6th week. Method of measurement: By asking the patients. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAzade kiani
Shiraz University of Medical Science
Outcome results
None listed